2Santos GW, Sensenbrener L, Burke PJ, et al. Marrow transplantation in man following cyclophosphamide [ J ]. Transplant Proc,1971, 2:400-404.
3Kumar S, Gupta RK, Bhake AS, et al. Cardiotoxic effects of high doses of cyclophosphamide in albino rats[ J ]. Arch Int Pharmacodyn Ther, 1992, 319:58-65.
4Hopkins HA, Betsill WL, Hobson Jr AS, et al. Cyclophosphamideinduced cardiomyopathy in the rat [ J]. Cancer Treatment Reports,1982, 66(7): 1 521 -1 527.
5Fraiser LH, Kanekal S, Kehrer JP. Cyclophosphamide toxicity:characterising and avoiding the problem[ J]. Drugs, 1991,42 (5):781 - 795.
6Colvin M, Hilton J. Pharmacology of cyclophosphamide and metabolites[J]. Cancer Treatment Reports, 1981, 65 ( Suppl. 3 ): S89- S95.
8Mills BA, Roberts RW. Cyclophosphamide-induced cardiomyopathy: a report of two cases and review of the English literature [ J ].Cancer, 1979,43:2 223 -2 226.
9Steinherz LJ, Steinherz PJ, Mangiacasale D, et al. Cardiac changes with cyclophosphamide[ J]. Med Pediatr Oncol, 1981, 9: 417-422.
10Braverman AC, Antin JH, Plappert MT, et al. Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens [ J ]. Journal of Clinical Oncology,1991, 9(7): 1 215-1 223.
